Optimal Sleep May Reduce Dementia Risk in Patients With Focal Epilepsy

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 24, 2026.

via HealthDay

FRIDAY, April 24, 2026 -- Optimal sleep duration is associated with better executive function, with a significantly higher impact of optimal sleep among those with focal epilepsy, according to a study published online April 22 in Neurology.

Xin You Tai, D.Phil., from the University of Oxford in the United Kingdom, and colleagues conducted an analysis of the prospective U.K. Biobank cohort study to examine the relationship between sleep and cognition and dementia risk in patients with focal epilepsy compared to healthy controls and patients with stroke. The sample included 482,207 participants, aged 38 to 72 years, without dementia at baseline and a nested imaging subsample of 42,345 participants.

The researchers found that in the control, focal epilepsy, and stroke groups, optimal sleep duration (six to eight hours) was associated with better executive function. Compared with controls, individuals with focal epilepsy, but not those with stroke, had a significantly higher impact from optimal sleep. There was an association seen for nonoptimal sleep with worse executive function up to eight years before diagnosis of focal epilepsy. Compared with healthy controls with optimal sleep, individuals with focal epilepsy and nonoptimal sleep had an increased risk for developing dementia (hazard ratio, 5.15); the risk was lower for individuals with stroke with poor sleep (hazard ratio, 3.48). Optimal versus nonoptimal sleep modified the dementia risk in individuals with focal epilepsy, with a significantly greater improvement versus healthy controls, while the stroke group exhibited no significant difference.

"Our study suggests getting optimal sleep may be especially beneficial to cognition and dementia risk in people with focal epilepsy," Tai said in a statement.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-25 09:02

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords